SignatureFD’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-77
Closed -$1.15K 3450
2022
Q4
$1.15K Sell
77
-223
-74% -$3.09K ﹤0.01% 2945
2022
Q3
$2K Buy
+300
New +$2.3K ﹤0.01% 2887
2018
Q4
Sell
-270
Closed -$9K 2134
2018
Q3
$9K Hold
270
﹤0.01% 1421
2018
Q2
$6K Buy
+270
New +$6.4K ﹤0.01% 1536

SignatureFD's AVEO Position: Q1 2023 in Review

SignatureFD sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 77 shares — an estimated $1.15K sold.

SignatureFD first reported a position in AVEO in Q2 2018 and held it in 4 quarters. The position peaked at $9K in Q3 2018. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • SignatureFD reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • SignatureFD sold 77 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $1.15K.
  • SignatureFD first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 4 quarters.
  • SignatureFD's AVEO Pharmaceuticals, Inc. position peaked at $9K in Q3 2018.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on SignatureFD's 13F filing for Q1 2023, filed 28 Apr 2023.